Jagielska , B., Czubek, A., Talasiewicz , K., Twarowski , A., Rutkowski , P., Krzakowski , M., Saetre , B., & Malecki , M. (2023). Assessment of efficacy of trastuzumab (Herceptin) comprising adjuvant therapy of HER2+ breast cancer patients determined based upon statistical analysis of overall survival (OS) and disease-free survival (PFS) . Molecular Cellular Therapy and Mechanism, 6(1), 37–49. Retrieved from https://journal.riverpublishers.com/index.php/MCTM/article/view/211